Pharmaceutical Executive, Oct 1, 2011 - Pharmaceutical Executive

ADVERTISEMENT

Pharmaceutical Executive, Oct 1, 2011
Features
Inside the Mind of the CEO
By William Looney
Pharm Exec sits down with Steve Collis, CEO of AmerisourceBergen to discuss his agenda for retooling the drug distribution giant.
Patient Advocacy: The Last 30 Years
By Jennifer Ringler
The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal.
Emerging Markets:The Myths and Traps
Success in the emerging markets depends significantly on navigating the myths and mental traps.
The Permanent Campaign
By Stan Bernard, MD
The product launch has been transformed from a concentrated, all-out military assault to the subtle, persuasive art of electioneering.
From the Editor
Pharm Exec:  30 Years,  30 Leaders
By William Looney
Pharm Exec celebrates its 30th birthday with a gathering of 30 of the industry's key influencers of the last three decades.
Profiles
Antonio Gotto: Pathfinder in Primary Care
By William Looney
Antonio Gotto, MD, Dean, Weill Cornell Medical College
Fernand Sauer: The Essential—and Effective—Bureaucrat
Fernand Sauer, First Director General, European Medicines Agency
Sir Michael Rawlins: Regulation and Reputation
Sir Michael Rawlins, Chairman of the UK National Institute for Health and Clinical Excellence
Partnering with the New Players
By William Looney
Carlos Morel, MD, Director for Technical Development in Health, Oswaldo Cruz Foundation
Martin Wygod: Arming up for the Digital Revolution
Martin Wygod, Chairman, WebMD
Francis Collins: Guiding a Revolution in Science
By Jill Wechsler
Francis Collins, MD, PhD, Director, National Institutes of Health
Fred Frank: Fortune and the Financier
Fred Frank, Vice Chairman, P.J. Solomon Co.
Janet Woodcock: At the Helm of Industry
By Jill Wechsler
Janet Woodcock, MD, Director, FDA Center for Drug Evaluation and Research
IP: Securing a Global Consensus—Can Industry Do It Again?
By Ansis Helmanis
Harvey Bale, Jr., MD, former Director-General, IFPMA
Sir Martin Sorrell: Teamwork and Trust
By William Looney
Sir Martin Sorrell, CEO, WPP
Abbey Meyers: The "Mother" of Invention
By Jennifer Ringler
Abbey Meyers, Founder, National Organization of Rare Disorders
Physicians: Still the Vital Connection in Medicine
Jean-Claude Labrune, Chairman & CEO, Cegedim Group
Y. K Hamied : Changing the Dialogue
Y.K. Hamied, PhD, Chairman, Cipla
Sidney Wolfe: Pharma's Unlikely Best Friend
By Jill Wechsler
Sidney Wolfe, MD, Director, Public Citizen's Health Research Group
Angus Russell: Bravura Performer
By William Looney
Angus Russell, CEO, Shire
In Establishing the Evidence Base, He Made Science Count
By David Balekdjian
Robert Seidman, Former Chief Pharmacy Officer, Wellpoint
Candan Carabagli: The East is Up
By William Looney
Candan Karabagli, CEO, Abdi Ibrahim A.S.
Josef von Rickenbach: The Enterprising CRO
By Ben Comer
Josef von Rickenbach, President & CEO, Parexel
Productivity, Reputation are Keys to Global Leadership
By William Looney
Yasuchika Hasegawa, President & CEO, Takeda Pharmaceutical Co.
Henry Grabowski: Academia Sweet Spot
Henry Grabowski, PhD, Professor of Economics, Duke University
Henry Waxman: "Representing" Healthcare to the Fullest
By Jill Wechsler
Henry Waxman, Congressional Representative from Los Angeles, California
Marck McLellan: An 'A' for Advancing Expectations
By Jill Wechsler
Marck McClellan, MD, Director, Engelberg Center for Health Reform, Brookings Institute
Peter Piot: The Crisis Manager
By William Looney
Peter Piot, MD, Director, London School of Hygiene and Tropical Medicine
Andrew Witty: The Legacy of High Expectations
Andrew Witty, Chairman & CEO, GlaxoSmithKline
Atsushi Nagahisa: Creating Customer Value
Atsushi Nagahisa, President & CEO, RaQualia
Napoleone Ferrara: Curative Powers of Collaboration
By William Looney
Napoleone Ferrara, MD, PhD, Research Fellow, Genentech
P. Roy Vagelos: Getting to No. 1—and Staying There
By William Looney
P. Roy Vagelos, MD, Chairman Emeritus, Merck
Dennis Gillings: Minting the Database
By William Looney
Dennis Gillings, Chairman & CEO, Quintils Transnational Corp.
Jane Henney: Lessons from the FDA Front Line
By Ansis Helmanis
Jane Henney, MD, Former FDA Commissioner
Sweden: Setting the Pace for Global Pharma
By Julian Upton
Garbo gets it ...
Daniel Vasella: Heart of Success
By Daniel Vasella, MD
Daniel Vasella, MD, Chairman, Novartis
Back Page
30 Years of Pharma: Perspective in Numbers, Part 3
Top 10 Companies by Market Share
30 Years of Pharma: Perspective in Numbers, Part 1
Top 10 Products Worldwide
Three Decades of Politics and Pop Culture ... on Drugs
By Jeff Schindler , Ben Comer
Three Decades of Politics and Pop Culture ... on Drugs
30 Years of Pharma: Perspective in Numbers, Part 2
30 Years of Pharma: Perspective in Numbers

ADVERTISEMENT

Click here